Synapse

← Frontiers in Malaria

Papers in Frontiers in Malaria

Page 1 · newest first

  1. Malaria among the population associated with illegal mining in the Yanomami Indigenous Land in Roraima, Brazil: challenges and perspectivesFrontiers in Malaria · 2026
  2. TaxoAttention: fusing semantic and hierarchical taxonomic models with attention-guided augmentation for mosquito identificationFrontiers in Malaria · 2026
  3. Human-relevant preclinical platforms for malaria: converging nanomedicine and organ-on-chip technologiesFrontiers in Malaria · 2026
  4. Jatropha curcas-derived curcusones B and C inhibit Plasmodium falciparum with preferential activity against late-ring and early-trophozoite stagesFrontiers in Malaria · 2026
  5. Mechanisms of insecticide resistance in mosquitoes and their implications for disease controlFrontiers in Malaria · 2026
  6. AI and silkworm biomanufacturing: a new paradigm for malaria therapeutics accessFrontiers in Malaria · 2026
  7. Cohort retention in seasonal malaria chemoprevention: an analysis of magnitude and associated factors in Northern Bahr el Ghazal, South SudanFrontiers in Malaria · 2026
  8. Advanced nanomaterials for malaria theranosticsFrontiers in Malaria · 2026
  9. Retrospective study of association between Plasmodium falciparum malaria density and platelet count at Presbyterian Hospital, AgogoFrontiers in Malaria · 2026
  10. Holding the line against artemisinin partial resistance in Africa: the case for preemptive treatment policyFrontiers in Malaria · 2026
  11. How do pro-inflammatory cytokines alter miRNA profiles in brain endothelial cells? Mechanisms, consequences, and therapeutic strategies for blood-brain barrier protectionFrontiers in Malaria · 2026
  12. Different agroecosystems have similar Anopheles–Microsporidia MB infection dynamics in the Ahero region of Western Kenya: implications for symbiont control strategiesFrontiers in Malaria · 2026
  13. Editorial: Addressing contemporary threats to global malaria control: new tools and strategiesSHILAP Revista de lepidopterología · 2026
  14. Stakeholders’ perceptions, acceptability, and sustainability of a larviciding intervention in Tanga Region, TanzaniaFrontiers in Malaria · 2025
  15. Prevalence and Plasmodium species distribution of asymptomatic malaria parasitemia among blood donors at the Lilongwe blood transfusion centerFrontiers in Malaria · 2025
  16. Genomic dynamics of clinical Plasmodium vivax: comparative genomic hybridization in severe malaria casesFrontiers in Malaria · 2025
  17. Efficacy of low-dose primaquine plus artemether-lumefantrine or dihydroartemisinin-piperaquine for radical cure of Plasmodium vivax in the Solomon Islands: a randomised clinical trialFrontiers in Malaria · 2025
  18. Specificity and kinetics of human candidate cerebral malaria biomarkers in miceFrontiers in Malaria · 2025
  19. Molecular polymorphism of Plasmodium vivax Duffy binding protein domain II from Nicaragua, and global diversity patternsFrontiers in Malaria · 2025
  20. Dynamic shift of malaria cases in northwest Ethiopia: a 10-year retrospective cohort data analysis from 2012 to 2021Frontiers in Malaria · 2025
  21. Knowledge, beliefs and adherence to antimalarial medications among patients in the Ga East Municipality of GhanaFrontiers in Malaria · 2025
  22. Efficacy of the spatial repellent SC Johnson Mosquito Shield™ against anophelines in free-flight chambers, semi-field systems, experimental huts, and in-home testsFrontiers in Malaria · 2025
  23. Laboratory efficacy of Bactivec® and Griselesf® biolarvicides used for large-scale larviciding in TanzaniaFrontiers in Malaria · 2025
  24. Impact of artemether–lumefantrine treatment, circadian rhythm, and serum replacement on the infectiousness of wild Plasmodium falciparum gametocytes to Anopheles gambiae sensu stricto mosquitoesFrontiers in Malaria · 2025
  25. Prevalence of Plasmodium falciparum infection in school-aged children in urban and peri-urban schools of Bamako, MaliFrontiers in Malaria · 2025
  26. Targeting mucosal immunity in malaria control: the underexplored role of IgAFrontiers in Malaria · 2025
  27. SC Johnson Guardian™ spatial repellent shows 1-year efficacy against wild pyrethroid-resistant Anopheles arabiensis, with a similar blood-feeding inhibition efficacy to Mosquito Shield™ in a Tanzanian experimental hut trialFrontiers in Malaria · 2025
  28. Beyond insecticide treated bed nets coverage to heterogeneous human behaviors and spatial realitiesFrontiers in Malaria · 2025
  29. Mosquito vector diversity and malaria transmissionFrontiers in Malaria · 2025
  30. Quantification of Plasmodium falciparum: validation of quantitative polymerase chain reaction assays for detection of parasites in controlled human malaria infection studiesFrontiers in Malaria · 2025
  31. Evaluating insecticide susceptibility in major African malaria vectors: a meta-analysis and systematic reviewFrontiers in Malaria · 2025
  32. Primaquine-induced hemoglobinuria: a case report of a G6PD deficient malaria patient with Mahidol trait from Bandarban, BangladeshFrontiers in Malaria · 2025
  33. PRONet Duo insecticide-treated net incorporated with chlorfenapyr and bifenthrin is superior to Interceptor® G2 nets against pyrethroid-resistant Anopheles gambiae sensu lato: a randomized experimental hut trial in Côte d’Ivoire and Tanzania using non-inferiority designFrontiers in Malaria · 2025
  34. Community perceptions and acceptability of insecticide-treated screens for mosquito proofing of unimproved houses in Chalinze district, Tanzania: a mixed-methods studyFrontiers in Malaria · 2025
  35. Malaria case management over 15 years (2006–2021) in Jakiri North-West Region CameroonFrontiers in Malaria · 2025
  36. Malaria “chemoprevention and vaccination strategies” for children living in endemic areas of Africa: a reviewFrontiers in Malaria · 2025
  37. Allelic variations in putative antimalarial drug resistance and vaccine candidate genes among Plasmodium vivax reference genomesFrontiers in Malaria · 2025
  38. High rate of false positive malaria rapid diagnostic tests in a district hospital in UgandaFrontiers in Malaria · 2025
  39. Can Ethiopia eliminate malaria? Malaria burden: insights from the pre-elimination era, current challenges and perspectivesFrontiers in Malaria · 2025
  40. Parasitological and clinical correlates of Plasmodium–Schistosoma mansoni co-infection and its determinants among Plasmodium-infected patients in the Wolaita Zone, South Ethiopia regional stateFrontiers in Malaria · 2025
  41. Molecular identification of pfcytb, pfdhfr, and pvmrp1 mutations in imported malaria cases in ChileFrontiers in Malaria · 2025
  42. Comparative efficacy of Vector Guard® to Olyset® Plus insecticide-treated nets against strongly pyrethroid-resistant Anopheles arabiensis in experimental huts in TanzaniaFrontiers in Malaria · 2024
  43. Burden and clinical characteristics of recurrent Plasmodium vivax infections, and impact of primaquine for radical cure: a systematic scoping review in IndiaFrontiers in Malaria · 2024
  44. Proteomic profile of plasma-derived extracellular vesicles from Colombian pregnant women with Plasmodium-soil transmitted helminths coinfectionFrontiers in Malaria · 2024
  45. Factors affecting treatment delays among malaria patients presenting at health facilities in Guinea, 2022–2023SHILAP Revista de lepidopterología · 2024
  46. Plasticity in malaria parasite development: mosquito resources influence vector-to-host transmission potentialFrontiers in Malaria · 2024
  47. Red blood cell dynamics during malaria infection challenge the assumptions of mathematical models of infection dynamicsFrontiers in Malaria · 2024
  48. A non-parametric approach to estimate multiplicity of infection and pathogen haplotype frequenciesFrontiers in Malaria · 2024
  49. Limited impact of within-vector ecology on the evolution of malaria parasite transmission investmentFrontiers in Malaria · 2024
  50. Agreement between serological data on schoolchildren and the number of malaria cases in the remaining high-burden villages of IndonesiaFrontiers in Malaria · 2024